Marine Natural Products as Leads against SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Marine Natural Products as Leads against SARS-CoV-2 Infection

Published:2022-03-15 Issue:3 Volume:85 Page:657-665
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Chhetri Bhuwan Khatri¹,Tedbury Philip R.²,Sweeney-Jones Anne Marie¹,Mani Luke³,Soapi Katy³,Manfredi Candela⁴,Sorscher Eric⁴,Sarafianos Stefan G.²^ORCID,Kubanek Julia¹⁵⁶⁷^ORCID

Affiliation:

1. School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

2. Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, United States

3. Institute of Applied Sciences, University of South Pacific, Suva, Fiji

4. Department of Pediatrics, Division of Pulmonary Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, United States

5. Center for Microbial Dynamics and Infection, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

6. School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

7. Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

Funder

National Institutes of Health

The Nahmias-Schinazi Chair fund at Emory University

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.2c00015

Reference91 articles.

1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (accessed 2022–03–07).

2. FDA Press Announcements Page. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19 (accessed 2021–11–04).

3. FDA Press Announcements Page. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain (accessed 2021–12–26).

4. Pfizer Press Releases page. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-us-fda-emergency-use-authorization-novel (accessed 2021–12–26).

5. FDA Press Announcements Page. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 (accessed 2021–12–26).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the inhibitory effects of some secondary amines, thioureas and 1,3-dimethyluracil conjugates of (-)-cytisine and thermopsine on the RNA-dependent RNA polymerase of SARS-CoV-1 and SARS-CoV-2;Bioorganic & Medicinal Chemistry Letters;2024-11

2. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11

3. Antiviral miliusanes and isolation of an unprecedented miliusane dimer from Miliusa balansae;Fitoterapia;2024-09

4. Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV-2 viral spike/ACE2 protein binding;The Microbe;2024-06

5. Facile Synthesis and First Antifungal Exploration of Tetracyclic Meroterpenoids: (+)-Aureol, (−)-Pelorol, and Its Analogs;Journal of Natural Products;2024-04-01